Celgene to tackle ‘undruggable’ targets with VividionCelgene has signed a deal with Vividion Therapeutics to develop drugs for oncology, inflammatory, and neurodegenerative diseases. Share XCelgene to tackle ‘undruggable’ targets with Vividionhttps://pharmaphorum.com/news/celgene-to-tackle-undruggable-targets-with-vividion/